ZCI
EXAS

Zevenbergen Capital Investments’s Exact Sciences EXAS Stock Holding History

Zevenbergen Capital Investments’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-302,777
Closed -$30.8M – 112
2025
Q4 		$30.8M Sell
302,777
-663,494
-69% -$53.3M 0.68% 37
2025
Q3 		$52.9M Sell
966,271
-51,912
-5% -$2.59M 1.03% 28
2025
Q2 		$54.1M Sell
1,018,183
-149,781
-13% -$7.61M 1.06% 29
2025
Q1 		$50.6M Sell
1,167,964
-208,093
-15% -$10.5M 1.23% 23
2024
Q4 		$77.3M Sell
1,376,057
-57,518
-4% -$3.58M 1.58% 21
2024
Q3 		$97.7M Sell
1,433,575
-29,340
-2% -$1.66M 2.05% 16
2024
Q2 		$61.8M Buy
1,462,915
+101,500
+7% +$5.58M 1.32% 24
2024
Q1 		$94M Buy
1,361,415
+231,591
+20% +$14.6M 2% 17
2023
Q4 		$83.6M Buy
1,129,824
+14,399
+1% +$944K 1.92% 18
2023
Q3 		$76.1M Sell
1,115,425
-25,995
-2% -$2.21M 1.94% 19
2023
Q2 		$107M Sell
1,141,420
-94,463
-8% -$7.37M 2.55% 12
2023
Q1 		$83.8M Sell
1,235,883
-149,445
-11% -$9.61M 2.25% 15
2022
Q4 		$68.6M Sell
1,385,328
-100,920
-7% -$4.12M 2.3% 17
2022
Q3 		$48.3M Buy
1,486,248
+7,412
+0.5% +$306K 1.37% 26
2022
Q2 		$58.3M Sell
1,478,836
-50,796
-3% -$2.72M 2.66% 13
2022
Q1 		$107M Sell
1,529,632
-87,766
-5% -$6.42M 2.88% 13
2021
Q4 		$126M Sell
1,617,398
-124,015
-7% -$10.9M 2.62% 13
2021
Q3 		$166M Sell
1,741,413
-64,449
-4% -$6.8M 3.15% 10
2021
Q2 		$224M Sell
1,805,862
-51,999
-3% -$6.21M 3.98% 6
2021
Q1 		$245M Buy
1,857,861
+39,395
+2% +$5.39M 4.65% 5
2020
Q4 		$241M Sell
1,818,466
-272,231
-13% -$32.9M 4.22% 7
2020
Q3 		$213M Buy
2,090,697
+105,268
+5% +$9.09M 4.28% 7
2020
Q2 		$173M Buy
1,985,429
+193,200
+11% +$15.4M 4.12% 9
2020
Q1 		$104M Buy
1,792,229
+235,330
+15% +$19.1M 3.92% 11
2019
Q4 		$144M Sell
1,556,899
-134,181
-8% -$11.8M 5.34% 4
2019
Q3 		$153M Sell
1,691,080
-57,363
-3% -$6.54M 5.85% 3
2019
Q2 		$206M Sell
1,748,443
-94,002
-5% -$9.47M 6.76% 1
2019
Q1 		$160M Sell
1,842,445
-312,912
-15% -$26.6M 5.66% 3
2018
Q4 		$136M Sell
2,155,357
-97,690
-4% -$6.7M 5.93% 3
2018
Q3 		$178M Buy
2,253,047
+182,877
+9% +$11.9M 5.64% 3
2018
Q2 		$124M Buy
2,070,170
+35,725
+2% +$1.92M 4.12% 6
2018
Q1 		$82M Buy
2,034,445
+152,900
+8% +$7.46M 3.15% 13
2017
Q4 		$98.9M Sell
1,881,545
-234,380
-11% -$12.5M 4.12% 7
2017
Q3 		$99.7M Sell
2,115,925
-155,570
-7% -$6.26M 4.33% 8
2017
Q2 		$80.3M Sell
2,271,495
-81,610
-3% -$2.52M 3.49% 10
2017
Q1 		$55.6M Buy
2,353,105
+25,335
+1% +$502K 2.56% 16
2016
Q4 		$31.1M Sell
2,327,770
-67,505
-3% -$1.09M 1.46% 29
2016
Q3 		$44.5M Sell
2,395,275
-339,535
-12% -$5.98M 1.83% 22
2016
Q2 		$33.5M Buy
2,734,810
+106,100
+4% +$799K 1.57% 29
2016
Q1 		$17.7M Buy
2,628,710
+311,955
+13% +$2M 0.8% 38
2015
Q4 		$21.4M Buy
2,316,755
+541,090
+30% +$5.03M 0.87% 36
2015
Q3 		$31.9M Buy
1,775,665
+442,585
+33% +$10.2M 1.37% 34
2015
Q2 		$39.6M Buy
1,333,080
+272,050
+26% +$6.83M 1.54% 32
2015
Q1 		$23.4M Buy
+1,061,030
New +$26.9M 0.98% 38

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Zevenbergen Capital Investments's EXAS Position: Q1 2026 in Review

Zevenbergen Capital Investments sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 302,777 shares — an estimated $30.8M sold.

Zevenbergen Capital Investments first reported a position in EXAS in Q1 2015 and held it in 44 quarters. The position peaked at $245M in Q1 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Zevenbergen Capital Investments reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Zevenbergen Capital Investments sold 302,777 Exact Sciences shares in Q1 2026, an estimated $30.8M.
  • Zevenbergen Capital Investments first reported a position in Exact Sciences in Q1 2015 and held it in 44 quarters.
  • Zevenbergen Capital Investments's Exact Sciences position peaked at $245M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Zevenbergen Capital Investments's 13F filing for Q1 2026, filed 9 Apr 2026.